Our take on the SEMDA 2019 Medtech Conference sponsorship value proposition.
GCMI’s mission is to accelerate the pathway to commercialization of innovative medical products. To accomplish this, we need to meet the innovators, the large strategics, investors and consultant partners who all need to work in concert to improve lives and reduce overall healthcare spending. The annual SEMDA Medtech Conference is a concentrated, high-value environment that supports those needs and goals.
The 2019 SEMDA Medtech Conference is April 8-10, 2019 at the Hotel Avalon in Alpharetta, Georgia. We have proudly been a sponsor for years in a row now because it is a value-based investment in our medtech ecosystem and business. The conference is a hub for the southeast healthcare ecosystem and beyond, for medtech education, learning, innovation and connection. It strikes a perfect balance between critical mass and intimacy.
We encourage all of our industry colleagues to consider a SEMDA 2019 Medtech Conference sponsorship because of the valuable opportunities for all stakeholders:
- Investors and large strategics – Medtech investing doesn’t work the same as in any other industry. It’s frequently a longer game with rules that can change quickly. The SEMDA Medtech Conference gives investors and large strategic medtech companies the opportunity to identify their next investable company and learn from those in the trenches bringing innovation to market and patient care in a capital efficient way. How can you de-risk your next medtech investment? Will one of this year’s PitchRounds companies be your next investment? You need to be there to find out.
- Startups and early growth stage companies – The SEMDA Medtech Conference is an excellent environment for medtech startups and early growth stage companies to build awareness for their technology while meeting prospective investors, vendor partners and acquirers. This also applies to individual entrepreneurs and innovators. Learning about what a large strategic like J&J Innovations or Avanos, in a one-on-one opportunity, believes makes a highly investable company is one example of the high-value opportunity SEMDA presents. How can you de-risk your innovation to make it more attractive to new investment? Find GCMI at SEMDA 2019 and ask us!
- Service Providers – Through our own experience and the experiences of colleagues, we know the SEMDA Medtech Conference generates new leads, new clients, new sponsors and new revenue. This is why professional service organizations like Marsh & McLennan, J.P. Morgan, BakerHostetler and Write2Market invest in SEMDA sponsorships year after year.
“The SEMDA Annual Conference has played a direct role in generating multiple new clients and associated revenue growth for the agency. It provides us access to hundreds of medtech entrepreneurs, growth stage companies and large corporations and institutions like the American Cancer Society among others. As the southeastern U.S. medtech ecosystem continues to grow, partnering with SEMDA helps the Write2Market healthcare practice stay informed, stay connected and generate opportunities to grow along with it.” – Paul Snyder, VP Healthcare, Write2Market
“Our partnership with SEMDA allows us to engage with the entire Southeastern medtech and medical device ecosystem. As such, we gain a better understanding of industry issues. SEMDA serves as the central connecting hub for the Southeast medtech community. We have met new companies at SEMDA that are now MMA clients. Through our involvement with SEMDA, we have been able to connect our clients with investors, suppliers, and specialists to help their business succeed.” – Courtney Warren, Marsh & McLennan Agency
You can find the SEMDA 2019 Medtech Conference sponsorship opportunities and brochure here.
Meet and engage the ecosystem in a highly concentrated opportunity. Build your medtech network, collaborate and learn by investing in SEMDA 2019 Medtech Conference. Come meet your peers and do something awesome! Make sure to find the GCMI team there to discuss the guidance we can provide to de-risk medical innovation and efficiently navigate the pathway from concept to commercialization. Contact us today to schedule an on-site meeting ahead of time!